Skip To Main Content
Určeno pro odbornou veřejnost
Campus
Campus
View Full Results

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
VIDEO BD MALADIE DE GAUCHER DE MERYEM en Arabe

VIDEO BD MALADIE DE GAUCHER DE MERYEM en Arabe

Číst více
Vidéo BD COMPRENDRE LA MALADIE DE GAUCHER DE SARAH

Vidéo BD COMPRENDRE LA MALADIE DE GAUCHER DE SARAH

Číst více
C'est quoi la maladie de Gaucher

C'est quoi la maladie de Gaucher

Číst více
The role of General Practitioners in the management of Type 1 Diabetes - Dr. Paula Diab

The role of General Practitioners in the management of Type 1 Diabetes - Dr. Paula Diab

Číst více
Insulin Pharmacology, Therapeutic Regimens & Principles of Intensive Insulin Therapy - Dr. Lesiba Mashitisho

Insulin Pharmacology, Therapeutic Regimens & Principles of Intensive Insulin Therapy - Dr. Lesiba Mashitisho

Číst více
A Practical Approach to the initiation, titration & intensification of injectables in Type 2 Diabetes - Dr. Angela Murphy

A Practical Approach to the initiation, titration & intensification of injectables in Type 2 Diabetes - Dr. Angela Murphy

Číst více
Use of 2nd Generation Basal Insulins in various Type 2 Diabetic populations - Dr. Jay Narainsamy

Use of 2nd Generation Basal Insulins in various Type 2 Diabetic populations - Dr. Jay Narainsamy

Číst více
Treatment options for T1D are changing

Treatment options for T1D are changing

TZIELD is the first and only immunomodulator indicated to delay the onset of Stage 3 T1D in patients aged 8 years and older with Stage 2 T1D. In the TN-10 study, one 2-week course of TZIELD doubled the median time to Stage 3 onset compared to placebo5. The median follow-up time was 51 months. In the extended follow-up of the TN-10 study, the median time to Stage 3 onset was approximately 5 years with TZIELD versus approximately 2 years with placebo6. Choose proactive intervention, Treat appropriate stage 2 T1D patients with TZIELD today.

Číst více
Phân Tích Tổng Hợp Cá Thể Bệnh Nhân Các Thử Nghiệm Ngẫu Nhiên Có Đối Chứng Về Liệu Pháp Xuống Thang Kháng Tiểu Cầu Kép Trong Hội Chứng Mạch Vành Cấp

Phân Tích Tổng Hợp Cá Thể Bệnh Nhân Các Thử Nghiệm Ngẫu Nhiên Có Đối Chứng Về Liệu Pháp Xuống Thang Kháng Tiểu Cầu Kép Trong Hội Chứng Mạch Vành Cấp

Číst více
Entre más temprano, mejor​

Entre más temprano, mejor​

¿Por qué es importante adelantarse a reducir los niveles de colesterol de los pacientes? Descúbralo aquí.

Číst více
Entre más bajo el colesterol, mejor​

Entre más bajo el colesterol, mejor​

¿Debe mantener bajo el nivel de colesterol del paciente?​

Číst více
Paradigmas en el manejo de la dislipidemia​

Paradigmas en el manejo de la dislipidemia​

¿Los niveles de colesterol deben realmente estar bajos? ¿Cuánto tiempo deben permanecer así? Descúbralo en esta lista de reproducción.

Číst více